Does psychological stress cause chronic pain?

Psychiatric Clinics of North America

Volumn 34, Issue 3, 2011, Pages 579-594

  Hassett, Afton L ^a   Clauw, Daniel J ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Chronic pain; Fibromyalgia; Neuroendocrine; Psychological stress

Indexed keywords

CATECHOL METHYLTRANSFERASE; GLUTAMIC ACID; GUANOSINE TRIPHOSPHATE CYCLOHYDROLASE I; POTASSIUM CHANNEL; POTASSIUM CHANNEL KCNS1; SODIUM CHANNEL NAV1.7; SODIUM CHANNEL NAV1.8; SODIUM CHANNEL NAV1.9; UNCLASSIFIED DRUG;

AUTOIMMUNE DISEASE; AUTONOMIC NERVOUS SYSTEM; BOLD SIGNAL; BRAIN FUNCTION; BRUCELLOSIS; CAUSAL ATTRIBUTION; CHRONIC PAIN; COMORBIDITY; DEPRESSION; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; EPSTEIN BARR VIRUS INFECTION; FIBROMYALGIA; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GENETIC ANALYSIS; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INTERSTITIAL CYSTITIS; IRRITABLE COLON; LYME DISEASE; MENTAL STRESS; OSTEOARTHRITIS; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; Q FEVER; REVIEW; RHEUMATOID ARTHRITIS; ROSS RIVER ALPHA VIRUS; TEMPOROMANDIBULAR JOINT DISORDER; TENSION HEADACHE;

AUTONOMIC NERVOUS SYSTEM; CHRONIC DISEASE; FIBROMYALGIA; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MODELS, PSYCHOLOGICAL; PAIN; STRESS, PSYCHOLOGICAL;

EID: 80052220116     PISSN: 0193953X     EISSN: 15583147     Source Type: Journal    
DOI: 10.1016/j.psc.2011.05.004     Document Type: Review

References (106)

1. Melzack R., Wall P.D. Pain mechanisms: a new theory. Science 1965, 150:971-979.
2. Lane R.D., Waldstein S.R., Critchley H.D., et al. The rebirth of neuroscience in psychosomatic medicine, Part II: clinical applications and implications for research. Psychosom Med 2009, 71:135-151.
3. Wolfe F., Smythe H.A., Yunus M.B., et al. The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 1990, 33:160-172.
4. Wolfe F., Clauw D.J., Fitzcharles M.A., et al. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res (Hoboken) 2010, 62:600-610.
5. Aaron L.A., Burke M.M., Buchwald D. Overlapping conditions among patients with chronic fatigue syndrome, fibromyalgia, and temporomandibular disorder. Arch Intern Med 2000, 160:221-227.
6. Hudson J.I., Hudson M.S., Pliner L.F., et al. Fibromyalgia and major affective disorder: a controlled phenomenology and family history study. Am J Psychiatry 1985, 142:441-446.
7. Arnold L.M., Hudson J.I., Hess E.V., et al. Family study of fibromyalgia. Arthritis Rheum 2004, 50:944-952.
8. Sperber A.D., Atzmon Y., Neumann L., et al. Fibromyalgia in the irritable bowel syndrome: studies of prevalence and clinical implications. Am J Gastroenterol 1999, 94:3541-3546.
9. Veale D., Kavanagh G., Fielding J.F., et al. Primary fibromyalgia and the irritable bowel syndrome: different expressions of a common pathogenetic process. Br J Rheumatol 1991, 30:220-222.
10. Wolfe F., Michaud K. Severe rheumatoid arthritis (RA), worse outcomes, comorbid illness, and sociodemographic disadvantage characterize ra patients with fibromyalgia. J Rheumatol 2004, 31:695-700.
11. Clauw D.J., Katz P. The overlap between fibromyalgia and inflammatory rheumatic disease: when and why does it occur?. J Clin Rheumatol 1995, 1:335-342.
12. Arnold L.M., Hudson J.I., Keck P.E., et al. Comorbidity of fibromyalgia and psychiatric disorders. J Clin Psychiatry 2006, 67:1219-1225.
13. Epstein S.A., Kay G., Clauw D., et al. Psychiatric disorders in patients with fibromyalgia. A multicenter investigation. Psychosomatics 1999, 40:57-63.
14. Hassett A.L., Radvanski D.C., Buyske S., et al. Psychiatric comorbidity and other psychological factors in patients with "chronic Lyme disease". Am J Med 2009, 122:843-850.
15. Raphael K.G., Janal M.N., Nayak S., et al. Psychiatric comorbidities in a community sample of women with fibromyalgia. Pain 2006, 124:117-125.
16. Hudson J.I., Goldenberg D.L., Pope H.G., et al. Comorbidity of fibromyalgia with medical and psychiatric disorders. Am J Med 1992, 92:363-367.
17. Bair M.J., Robinson R.L., Katon W., et al. Depression and pain comorbidity: a literature review. Arch Intern Med 2003, 163:2433-2445.
18. Culpepper L. Generalized anxiety disorder and medical illness. J Clin Psychiatry 2009, 70(Suppl 2):20-24.
19. Hassett A.L., Cone J.D., Patella S.J., et al. The role of catastrophizing in the pain and depression of women with fibromyalgia syndrome. Arthritis Rheum 2000, 43:2493-2500.
20. Edwards R.R., Bingham C.O., Bathon J., et al. Catastrophizing and pain in arthritis, fibromyalgia, and other rheumatic diseases. Arthritis Rheum 2006, 55:325-332.
21. Shuster J., McCormack J., Pillai Riddell R., et al. Understanding the psychosocial profile of women with fibromyalgia syndrome. Pain Res Manag 2009, 14:239-245.
22. Hassett A.L., Simonelli L.E., Radvanski D.C., et al. The relationship between affect balance style and clinical outcomes in fibromyalgia. Arthritis Rheum 2008, 59:833-840.
23. Zautra A.J., Fasman R., Reich J.W., et al. Fibromyalgia: evidence for deficits in positive affect regulation. Psychosom Med 2005, 67:147-155.
24. Karsdorp P.A., Vlaeyen J.W. Active avoidance but not activity pacing is associated with disability in fibromyalgia. Pain 2009, 147:29-35.
25. Giesecke T., Williams D.A., Harris R.E., et al. Subgrouping of fibromyalgia patients on the basis of pressure-pain thresholds and psychological factors. Arthritis Rheum 2003, 48:2916-2922.
26. Turk D.C., Okifuji A., Sinclair J.D., et al. Pain, disability, and physical functioning in subgroups of patients with fibromyalgia. J Rheumatol 1996, 23:1255-1262.
27. Raphael K.G., Janal M.N., Nayak S. Comorbidity of fibromyalgia and posttraumatic stress disorder symptoms in a community sample of women. Pain Med 2004, 5:33-41.
28. Finestone H.M., Stenn P., Davies F., et al. Chronic pain and health care utilization in women with a history of childhood sexual abuse. Child Abuse Negl 2000, 24:547-556.
29. Hudson J.I., Pope H.G. Does childhood sexual abuse cause fibromyalgia?. Arthritis Rheum 1995, 38:161-163.
30. McBeth J., Macfarlane G.J., Benjamin S., et al. Features of somatization predict the onset of chronic widespread pain: results of a large population-based study. Arthritis Rheum 2001, 44:940-946.
31. Papageorgiou A.C., Silman A.J., Macfarlane G.J. Chronic widespread pain in the population: a seven year follow up study. Ann Rheum Dis 2002, 61:1071-1074.
32. Croft P. The epidemiology of pain: the more you have, the more you get. Ann Rheum Dis 1996, 55:859-860.
33. McBeth J., Macfarlane G.J., Silman A.J. Does chronic pain predict future psychological distress?. Pain 2002, 96:239-245.
34. McLean S.A., Clauw D.J. Predicting chronic symptoms after an acute "stressor"-lessons learned from 3 medical conditions. Med. Hypotheses 2004, 63:653-658.
35. Jones G.T., Power C., Macfarlane G.J. Adverse events in childhood and chronic widespread pain in adult life: results from the 1958 British Birth Cohort Study. Pain 2009, 143:92-96.
36. McBeth J., Silman A.J., Gupta A., et al. Moderation of psychosocial risk factors through dysfunction of the hypothalamic-pituitary-adrenal stress axis in the onset of chronic widespread musculoskeletal pain: findings of a population-based prospective cohort study. Arthritis Rheum 2007, 56:360-371.
37. Hassett A.L., Sigal L.H. Unforeseen consequences of terrorism: medically unexplained symptoms in a time of fear. Arch Intern Med 2002, 162:1809-1813.
38. Raphael K.G., Natelson B.H., Janal M.N., et al. A community-based survey of fibromyalgia-like pain complaints following the World Trade Center terrorist attacks. Pain 2002, 100:131-139.
39. Williams D.A., Brown S.C., Clauw D.J., et al. Self-reported symptoms before and after September 11 in patients with fibromyalgia. JAMA 2003, 289:1637-1638.
40. Affleck G., Urrows S., Tennen H., et al. Sequential daily relations of sleep, pain intensity, and attention to pain among women with fibromyalgia. Pain 1996, 68:363-368.
41. Demitrack M.A., Crofford L.J. Evidence for and pathophysiologic implications of hypothalamic-pituitary-adrenal axis dysregulation in fibromyalgia and chronic fatigue syndrome. Ann N Y Acad Sci 1998, 840:684-697.
42. Crofford L.J., Pillemer S.R., Kalogeras K.T., et al. Hypothalamic-pituitary-adrenal axis perturbations in patients with fibromyalgia. Arthritis Rheum 1994, 37:1583-1592.
43. Qiao Z.G., Vaeroy H., Morkrid L. Electrodermal and microcirculatory activity in patients with fibromyalgia during baseline, acoustic stimulation and cold pressor tests. J Rheumatol 1991, 18:1383-1389.
44. Vaeroy H., Qiao Z.G., Morkrid L., et al. Altered sympathetic nervous system response in patients with fibromyalgia (fibrositis syndrome). J Rheumatol 1989, 16:1460-1465.
45. Heim C., Nater U.M., Maloney E., et al. Childhood trauma and risk for chronic fatigue syndrome: association with neuroendocrine dysfunction. Arch Gen Psychiatry 2009, 66:72-80.
46. Penza K.M., Heim C., Nemeroff C.B. Neurobiological effects of childhood abuse: implications for the pathophysiology of depression and anxiety. Arch Womens Ment Health 2003, 6:15-22.
47. McLean S.A., Williams D.A., Harris R.E., et al. Momentary relationship between cortisol secretion and symptoms in patients with fibromyalgia. Arthritis Rheum 2005, 52:3660-3669.
48. Wingenfeld K., Nutzinger D., Kauth J., et al. Salivary cortisol release and hypothalamic pituitary adrenal axis feedback sensitivity in fibromyalgia is associated with depression but not with pain. J Pain 2010, 11:1195-1202.
49. Cohen H., Neumann L., Shore M., et al. Autonomic dysfunction in patients with fibromyalgia: application of power spectral analysis of heart rate variability. Semin Arthritis Rheum 2000, 29:217-227.
50. Martinez-Lavin M., Hermosillo A.G., Rosas M., et al. Circadian studies of autonomic nervous balance in patients with fibromyalgia: a heart rate variability analysis. Arthritis Rheum 1998, 41:1966-1971.
51. Joyner M.J., Masuki S. POTS versus deconditioning: the same or different?. Clin Auton Res 2008, 18:300-307.
52. Dorfman T.A., Rosen B.D., Perhonen M.A., et al. Diastolic suction is impaired by bed rest: MRI tagging studies of diastolic untwisting. J Appl Physiol 2008, 104:1037-1044.
53. Glass J.M., Lyden A.K., Petzke F., et al. The effect of brief exercise cessation on pain, fatigue, and mood symptom development in healthy, fit individuals. J Psychosom Res 2004, 57:391-398.
54. McBeth J., Chiu Y.H., Silman A.J., et al. Hypothalamic-pituitary-adrenal stress axis function and the relationship with chronic widespread pain and its antecedents. Arthritis Res Ther 2005, 7:R992-R1000.
55. McLean S.A., Williams D.A., Stein P.K., et al. Cerebrospinal fluid corticotropin-releasing factor concentration is associated with pain but not fatigue symptoms in patients with fibromyalgia. Neuropsychopharmacology 2006, 31:2776-2782.
56. Woolf C.J. What is this thing called pain?. J Clin Invest 2010, 120:3742-3744.
57. Munakata J., Naliboff B., Harraf F., et al. Repetitive sigmoid stimulation induces rectal hyperalgesia in patients with irritable bowel syndrome. Gastroenterology 1997, 112:55-63.
58. Maixner W., Fillingim R., Booker D., et al. Sensitivity of patients with painful temporomandibular disorders to experimentally evoked pain. Pain 1995, 63:341-351.
59. Petzke F., Clauw D.J., Ambrose K., et al. Increased pain sensitivity in fibromyalgia: effects of stimulus type and mode of presentation. Pain 2003, 105:403-413.
60. Clauw D.J., Schmidt M., Radulovic D., et al. The relationship between fibromyalgia and interstitial cystitis. Journal of Psychiatric Research 1997, 31:125-131.
61. Lautenbacher S., Rollman G.B., McCain G.A. Multi-method assessment of experimental and clinical pain in patients with fibromyalgia. Pain 1994, 59:45-53.
62. Mense S., Hoheisel U., Reinert A. The possible role of substance P in eliciting and modulating deep somatic pain. Progress in Brain Research 1996, 110:125-135.
63. Geisser M.E., Glass J.M., Rajcevska L.D., et al. A psychophysical study of auditory and pressure sensitivity in patients with fibromyalgia and healthy controls. J Pain 2008, 9:417-422.
64. Geisser M.E., Gracely R.H., Giesecke T., et al. The association between experimental and clinical pain measures among persons with fibromyalgia and chronic fatigue syndrome. Eur J Pain 2007, 11:202-207.
65. Harris R.E., Gracely R.H., McLean S.A., et al. Comparison of clinical and evoked pain measures in fibromyalgia. J Pain 2006, 7:521-527.
66. Normand E., Potvin S., Gaumond I., et al. Pain inhibition is deficient in chronic widespread pain but normal in major depressive disorder. J Clin Psychiatry 2011, 72:219-224.
67. Giesecke T., Gracely R.H., Williams D.A., et al. The relationship between depression, clinical pain, and experimental pain in a chronic pain cohort. Arthritis Rheum 2005, 52:1577-1584.
68. Gracely R.H., Petzke F., Wolf J.M., et al. Functional magnetic resonance imaging evidence of augmented pain processing in fibromyalgia. Arthritis Rheum 2002, 46:1333-1343.
69. Giesecke T., Gracely R.H., Grant M.A., et al. Evidence of augmented central pain processing in idiopathic chronic low back pain. Arthritis Rheum 2004, 50:613-623.
70. Cook D.B., Lange G., Ciccone D.S., et al. Functional imaging of pain in patients with primary fibromyalgia. J Rheumatol 2004, 31:364-378.
71. Naliboff B.D., Derbyshire S.W., Munakata J., et al. Cerebral activation in patients with irritable bowel syndrome and control subjects during rectosigmoid stimulation. Psychosom Med 2001, 63:365-375.
72. Mayer E.A., Naliboff B.D., Craig A.D. Neuroimaging of the brain-gut axis: from basic understanding to treatment of functional GI disorders. Gastroenterology 2006, 131:1925-1942.
73. Gwilym S.E., Keltner J.R., Warnaby C.E., et al. Psychophysical and functional imaging evidence supporting the presence of central sensitization in a cohort of osteoarthritis patients. Arthritis Rheum 2009, 61:1226-1234.
74. Gracely R.H., Geisser M.E., Giesecke T., et al. Pain catastrophizing and neural responses to pain among persons with fibromyalgia. Brain 2004, 127(Pt 4):835-843.
75. Harris R.E., Sundgren P.C., Pang Y., et al. Dynamic levels of glutamate within the insula are associated with improvements in multiple pain domains in fibromyalgia. Arthritis Rheum 2008, 58:903-907.
76. Craig A.D. How do you feel?. Interoception: the sense of the physiological condition of the body. Nat Rev Neurosci 2002, 3:655-666.
77. Fishbain D. Evidence-based data on pain relief with antidepressants. Ann Med 2000, 32:305-316.
78. Arnold L.M. Duloxetine and other antidepressants in the treatment of patients with fibromyalgia. Pain Med 2007, 8(Suppl 2):S63-S74.
79. Hudson J.I., Pope H.G. The relationship between fibromyalgia and major depressive disorder. Rheum Dis Clin North Am 1996, 22:285-303.
80. Buskila D., Neumann L., Hazanov I., et al. Familial aggregation in the fibromyalgia syndrome. Semin Arthritis Rheum 1996, 26:605-611.
81. Kato K., Sullivan P.F., Evengard B., et al. Chronic widespread pain and its comorbidities: a population-based study. Arch Intern Med 2006, 166:1649-1654.
82. Hudson J.I., Arnold L.M., Keck P.E., et al. Family study of fibromyalgia and affective spectrum disorder. Biol Psychiatry 2004, 56:884-891.
83. Raphael K.G., Janal M.N., Nayak S., et al. Familial aggregation of depression in fibromyalgia: a community-based test of alternate hypotheses. Pain 2004, 110:449-460.
84. Yunus M.B. Central sensitivity syndromes: a new paradigm and group nosology for fibromyalgia and overlapping conditions, and the related issue of disease versus illness. Semin Arthritis Rheum 2008, 37:339-352.
85. Mogil J.S., Wilson S.G., Bon K., et al. Heritability of nociception. II. 'Types' of nociception revealed by genetic correlation analysis. Pain 1999, 80:83-93.
86. Mogil J.S., Wilson S.G., Bon K., et al. Heritability of nociception I: responses of 11 inbred mouse strains on 12 measures of nociception. Pain 1999, 80:67-82.
87. Costigan M., Belfer I., Griffin R.S., et al. Multiple chronic pain states are associated with a common amino acid-changing allele in KCNS1. Brain 2010, 133:2519-2527.
88. Tegeder I., Adolph J., Schmidt H., et al. Reduced hyperalgesia in homozygous carriers of a GTP cyclohydrolase 1 haplotype. Eur J Pain 2008, 12:1069-1077.
89. Tegeder I., Costigan M., Griffin R.S., et al. GTP cyclohydrolase and tetrahydrobiopterin regulate pain sensitivity and persistence. Nat Med 2006, 12:1269-1277.
90. Amaya F., Wang H., Costigan M., et al. The voltage-gated sodium channel Na(v)1.9 is an effector of peripheral inflammatory pain hypersensitivity. J Neurosci 2006, 26:12852-12860.
91. Nackley A.G., Tan K.S., Fecho K., et al. Catechol-O-methyltransferase inhibition increases pain sensitivity through activation of both beta2- and beta3-adrenergic receptors. Pain 2007, 128:199-208.
92. Diatchenko L., Anderson A.D., Slade G.D., et al. Three major haplotypes of the beta2 adrenergic receptor define psychological profile, blood pressure, and the risk for development of a common musculoskeletal pain disorder. Am J Med Genet B Neuropsychiatr Genet 2006, 141:449-462.
93. Diatchenko L., Slade G.D., Nackley A.G., et al. Genetic basis for individual variations in pain perception and the development of a chronic pain condition. Hum Mol Genet 2005, 14:135-143.
94. Buskila D., Sarzi-Puttini P., Ablin J.N. The genetics of fibromyalgia syndrome. Pharmacogenomics 2007, 8:67-74.
95. Clauw D.J., Engel C.C., Aronowitz R., et al. Unexplained symptoms after terrorism and war: an expert consensus statement. J Occup Environ Med 2003, 45:1040-1048.
96. McLean S.A., Clauw D.J., Abelson J.L., et al. The development of persistent pain and psychological morbidity after motor vehicle collision: integrating the potential role of stress response systems into a biopsychosocial model. Psychosom Med 2005, 67:783-790.
97. Ortega-Hernandez O.D., Shoenfeld Y. Infection, vaccination, and autoantibodies in chronic fatigue syndrome, cause or coincidence?. Ann N Y Acad Sci 2009, 1173:600-609.
98. Ablin J.N., Buskila D., Clauw D.J. Biomarkers in fibromyalgia. Curr Pain Headache Rep 2009, 13:343-349.
99. Buchwald D., Goldenberg D.L., Sullivan J.L., et al. The "chronic, active Epstein-Barr virus infection" syndrome and primary fibromyalgia. Arthritis Rheum 1987, 30:1132-1136.
100. Whelton C.L., Salit I., Moldofsky H. Sleep, Epstein-Barr virus infection, musculoskeletal pain, and depressive symptoms in chronic fatigue syndrome. J Rheumatol 1992, 19:939-943.
101. Hassett A.L., Radvanski D.C., Buyske S., et al. Role of psychiatric comorbidity in chronic Lyme disease. Arthritis Rheum 2008, 59:1742-1749.
102. Dinerman H., Steere A.C. Lyme disease associated with fibromyalgia. Ann Intern Med 1992, 117:281-285.
103. Hickie I., Davenport T., Wakefield D., et al. Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study. BMJ 2006, 333:575.
104. Vollmer-Conna U., Cameron B., Hadzi-Pavlovic D., et al. Postinfective fatigue syndrome is not associated with altered cytokine production. Clin Infect Dis 2007, 45:732-735.
105. Halvorson H.A., Schlett C.D., Riddle M.S. Postinfectious irritable bowel syndrome-a meta-analysis. Am J Gastroenterol 2006, 101:1894-1899.
106. Warren J.W., Howard F.M., Cross R.K., et al. Antecedent nonbladder syndromes in case-control study of interstitial cystitis/painful bladder syndrome. Urology 2009, 73:52-57.